ARCHIVES

New Mexico, Michigan Win Saturation Implementation Contracts

This article is from The Cancer Letter archive.

Vol. 01 No. 23 | June 6, 1975

Download PDF Visit The Full Archive

Related Articles

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001

Vidaza For MDS Approved; sNDAs for Taxotere, Gemzar

May 28, 2004

Cancer Nurses Urged To Take ‘Proactive Stance’ against Budget Cutting

October 16, 1987

Upton Still Mum On Leaving; DeVita Ever More Likely as Replacement

November 30, 1979

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

September 10, 1976

DCT Board Okays Concepts Of Four New Grant Projects, Four Competitive Contract Delays Chlordane Study

March 9, 1984